Skip to main content
. 2009 Dec;68(6):906–915. doi: 10.1111/j.1365-2125.2009.03534.x

Figure 5.

Figure 5

Absolute voriconazole bioavailability (mean and 95% confidence interval) for the three CYP2C19 genotypes. No significant differences between the genotypes (Kruskal–Wallis test with Dunn's multiple comparisons test)